Copyright © 2004 by the European Society of Cardiology.
Clinical research
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
a Institute of Cardiology, Hospital Pitie-Salpetriere, Paris, France
b Department of Coronary Disease, Institute of Cardiology, Krakow, Poland
c Department of Biostatistics, Pitie-Salpetriere Hospital, Paris, France
Received November 5, 2003; revised June 14, 2004; accepted July 15, 2004 * Corresponding author. Tel.: +33 1 42 16 30 09; fax: +33 1 42 17 67 19/16 30 20 (E-mail: richard.isnard{at}psl.ap-hop-paris.fr).
See page 1763 for the editorial comment on this article (doi:10.1016/j.ehj.2004.08.012)
AIMS: Comparison of the value of echocardiography and B-type natriuretic peptide (BNP) in monitoring response to treatment in patients admitted for acute heart failure (HF).
METHODS AND RESULTS: Ninety-five consecutive patients admitted with acute HF underwent bedside Doppler echocardiography and BNP measurements on admission, after 24 h of intravenous treatment, and at day 7. We then studied the association between the clinical status, the Doppler echocardiographic findings, the BNP measurements and subsequent 60-day adverse outcome (death, resuscitated cardiac arrest, urgent heart transplantation, readmission).
On admission and during hospitalisation, relationships were found between plasma BNP and Doppler echocardiographic findings, and between their changes. During a 60 day follow-up, 37 events occurred. Multivariable analysis taking into account clinical factors, Doppler echocardiography and BNP showed that the two best models to predict outcome were (1) early evaluation at day 2 (previous CHF treatment, dobutamine use, relative BNP change during first 24 h) and (2) late evaluation at day 7 (previous CHF treatment, dobutamine use, BNP at day 7). Patients with a decrease in plasma BNP >10% at day 2, or with plasma BNP <300 pg/ml at day 7 had a better outcome than the others (19% versus 65% and 16% versus 72% events, respectively, p<0.0001).
CONCLUSIONS: Serial BNP measurements during the treatment of acute HF provide incremental prognostic information over clinical presentation and repetitive echocardiographic examination.
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- BNP or echocardiography for monitoring heart failure?
- John E. Sanderson
EHJ 2004 25: 1763-1764.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  J. S. Ross, G. K. Mulvey, B. Stauffer, V. Patlolla, S. M. Bernheim, P. S. Keenan, and H. M. Krumholz Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review Arch Intern Med, July 14, 2008; 168(13): 1371 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Pascual-Figal, M. Domingo, T. Casas, I. Gich, J. Ordonez-Llanos, P. Martinez, J. Cinca, M. Valdes, J. L. Januzzi, and A. Bayes-Genis Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients Eur. Heart J., April 2, 2008; 29(8): 1011 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Verdejo, P. F. Castro, R. Concepcion, M. A. Ferrada, M. A. Alfaro, M. E. Alcaino, C. C. Deck, and R. C. Bourge Comparison of a Radiofrequency-Based Wireless Pressure Sensor to Swan-Ganz Catheter and Echocardiography for Ambulatory Assessment of Pulmonary Artery Pressure in Heart Failure J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2375 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duckelmann, F. Mittermayer, D. G. Haider, J. Altenberger, J. Eichinger, and M. Wolzt Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart Failure Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 2037 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Gary Nicholls, A Mark Richards, and Christchurch Cardioendocrine Research Group Disease monitoring of patients with chronic heart failure Heart, April 1, 2007; 93(4): 519 - 523. [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Huang, E.-T. Wu, W.-J. Ko, L.-P. Lai, J. Hsu, C.-I. Chang, I.-S. Chiu, S.-S. Wang, M.-H. Wu, F.-Y. Lin, et al. Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support Ann. Thorac. Surg., June 1, 2006; 81(6): 2267 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]
|
|
|
|
|
|
A. A. Chen, M. J. Wood, D. G. Krauser, A. L. Baggish, R. Tung, S. Anwaruddin, M. H. Picard, and J. L. Januzzi NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy Eur. Heart J., April 1, 2006; 27(7): 839 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sanderson BNP or echocardiography for monitoring heart failure? Eur. Heart J., October 2, 2004; 25(20): 1763 - 1764. [Full Text] [PDF]
|
|